Coya Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| COYA 302 | Amyotrophic Lateral Sclerosis (ALS) | Phase 2 |
| COYA 301 | Undisclosed (Treg Enhancing Biologic) | Not Disclosed |
| COYA 201 | Undisclosed (Allogeneic Treg-Derived Exosomes) | Not Disclosed |
| COYA 101 | Undisclosed (Autologous Treg Cell Therapy) | Not Disclosed |